Identity and authority
Legal entity, website/domain, responsible people, titles, location, ownership/control concerns, signatory authority, advisors, and conflicts.
Qualify identity • Fit • Authority • Next step
Strategic Partner Inquiry Framework
Aurora welcomes serious non-confidential inquiries from qualified engineering firms, manufacturers, laboratories, universities, research organizations, technology companies, and commercialization partners. Initial contact should establish fit before sensitive disclosure.
Public scopeNon-confidential structure, readiness, and inquiry routing.
Evidence languageConcept, analysis, simulation, prototype, and test remain
distinct.
No implied statusNo patent, funding, clearance, partnership, or job claim without
verification.
Controlled detailEnabling, restricted, personal, and privileged records remain
offline.
Structure
Operating framework
The public page explains the decision structure while detailed records remain controlled offline.
Technical fit
Relevant facilities, engineers, manufacturing/testing capability, certifications, domain history, quality system, capacity, and evidence of comparable work.
Commercial fit
Market/channel, customer problem, budget, timing, decision process, development appetite, business model, and competing obligations.
Rights and compliance
Background IP, competing programs, publication, data, export, security, privacy, FDA/device or other regulated-domain issues.
Proposed first step
Non-confidential call, expert review, feasibility statement, sample requirement, mutual NDA, facility capability review, or term-sheet discussion.
Decision record
Advance, pause, decline, or request evidence; document reasons, owner, deadline, disclosure limit, and next gate.
Sequence
Decision sequence
Each stage produces a reviewable record before the next commitment is made.
01 — ReceiveNon-confidential identity, capability, interest, and requested
action.
02 — VerifyOrganization, people, authority, conflicts, location, and public
evidence.
03 — FitTechnical, commercial, schedule, rights, and compliance
assessment.
04 — ProtectApprove NDA and disclosure plan only when warranted.
05 — AdvanceDefine study, diligence, term sheet, project, or respectful
decline.
Operating note: The most useful first inquiry names
the specific Aurora program, explains the organization’s relevant
capability, identifies the desired relationship, and proposes one
bounded next step.
Important limit: Do not send confidential designs,
source code, controlled technical data, patient information,
export-controlled material, or investment materials through the
initial contact route.
Continue